🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524570-41-00
Completed Phase I

A clinical trial of MK-6916 in healthy participants (MK-6916-010)

2025-524570-41-00 · tracked via the Priya Life Science EU tracker
Sponsor
Merck Sharp & Dohme LLC
Sponsor type
Pharmaceutical company
Therapeutic area
Nervous System Diseases
Decision date
02/03/2026
Enrollment target
54
Sites
Belgium

Condition studied

Acute and Chronic pain

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524570-41-00 on CTIS ↗ ← All trials in the EU